Command Palette

Search for a command to run...

NURECA

250.88-0.37%
Market Cap
₹241.55 Cr
Stock P/E
-184.25
ROCE
-1.06%
ROE
-0.92%
Book Value
₹193.11

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

Financials

YoY Net Sales
EPS Growth
Operating Margin

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Broad-Based Selling

Nureca Ltd. is facing significant financial challenges compared to its peers in the Medical Equipment/Supplies/Accessories sector. With negative earnings, low profitability metrics, and overvaluation, it appears to be underperforming. Meanwhile, Poly Medicure Ltd. stands out as a strong competitor with solid profitability and growth metrics, while other peers exhibit varying degrees of financial health and valuation attractiveness.

Key Points
  • Nureca Ltd. has the lowest profitability metrics and highest PE ratio indicating overvaluation.
  • Poly Medicure Ltd. shows strong growth and profitability metrics, making it a top performer in the sector.
  • Several companies exhibit weak financials or are overvalued based on their returns and margins.
Top Performers
Poly Medicure Ltd.

Strong revenue growth (21.37% YoY), high ROE (16.01%), and a reasonable PE ratio (63.37) make it a leader in the sector.

Prevest Denpro Ltd.

High ROE (18.70%), low debt (0), and a reasonable PE ratio (37.56) indicate solid financial health.